Michael Tang

Circulating mature granzyme B+ T cells distinguish Crohn’s disease-associated axial spondyloarthritis from axial spondyloarthritis and Crohn’s disease

Single-cell transcriptome landscape of circulating CD4+ T cell populations in autoimmune diseases

Dendritic cells in cancer immunology and immunotherapy

Myeloid-derived suppressor cells coming of age

Macrophages in immunoregulation and therapeutics

Dendritic Cells and Cancer Immunity

Vaccination with Messenger RNA: A Promising Alternative to DNA Vaccination

Immune crosstalk in cancer progression and metastatic spread: a complex conversation

Inflammation and tumor progression: signaling pathways and targeted intervention

Revisiting the gut–joint axis: links between gut inflammation and spondyloarthritis

Dendritic cells in cancer: the role revisited

The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth

PTPN2 links colonic and joint inflammation in experimental autoimmune arthritis

Macrophages as regulators of tumour immunity and immunotherapy

PGE2-EP2/EP4 signaling elicits immunosuppression by driving the mregDC-Treg axis in inflammatory tumor microenvironment

Differential inflammatory response to Helicobacter pylori infection: etiology and clinical outcomes

Re-Emergence of Dendritic Cell Vaccines for Cancer Treatment

A guide to cancer immunotherapy: from T cell basic science to clinical practice

Interleukin-6 receptor and its ligand interleukin-6 are opposite markers for survival and infiltration with mature myeloid cells in ovarian cancer

TLR1/2 ligand enhances antitumor efficacy of CTLA-4 blockade by increasing intratumoral Treg depletion

ICOS⁺Foxp3⁺TILs in gastric cancer are prognostic markers and effector regulatory T cells associated withHelicobacter pylori

The Tumor Microenvironment Innately Modulates Cancer Progression

De-Risking Immunotherapy: Report of a Consensus Workshop of the Cancer Immunotherapy Consortium of the Cancer Research Institute

Molecular mechanisms involved in dendritic cell dysfunction in cancer

Toll-like Receptor 2 Activation Promotes Tumor Dendritic Cell Dysfunction by Regulating IL-6 and IL-10 Receptor Signaling

Immunostimulatory conventional dendritic cells evolve into regulatory macrophage-like cells

<b><i>Helicobacter pylori</i></b> Inhibits Dendritic Cell Maturation via Interleukin-10-Mediated Activation of the Signal Transducer and Activator of Transcription 3 Pathway

Altered Cytotoxicity Profile of CD8+ T Cells in Ankylosing Spondylitis